1. Home
  2. PHAR vs UCTT Comparison

PHAR vs UCTT Comparison

Compare PHAR & UCTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$16.39

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Ultra Clean Holdings Inc.

UCTT

Ultra Clean Holdings Inc.

HOLD

Current Price

$24.99

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHAR
UCTT
Founded
1988
1991
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
PHAR
UCTT
Price
$16.39
$24.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$30.00
$32.50
AVG Volume (30 Days)
21.0K
571.1K
Earning Date
11-06-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
N/A
Revenue
$362,274,000.00
$2,110,600,000.00
Revenue This Year
$24.80
N/A
Revenue Next Year
$6.84
$5.74
P/E Ratio
$3,084.39
N/A
Revenue Growth
26.78
6.65
52 Week Low
$7.50
$16.66
52 Week High
$18.12
$40.10

Technical Indicators

Market Signals
Indicator
PHAR
UCTT
Relative Strength Index (RSI) 49.79 44.47
Support Level $15.76 $26.25
Resistance Level $18.12 $28.73
Average True Range (ATR) 0.83 1.21
MACD -0.12 0.08
Stochastic Oscillator 28.81 18.21

Price Performance

Historical Comparison
PHAR
UCTT

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

About UCTT Ultra Clean Holdings Inc.

Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments Products and Services. Its principal markets are Americas, Asia Pacific and EMEA.

Share on Social Networks: